CSBR vs CVS · P/E 16, rev $56.9M vs P/E 16, rev $402.07B
Champions Oncology Inc (CSBR) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CSBR and CVS stock pages for the full models.
Not investment advice.